When her dad was diagnosed with pancreatic cancer, PanCAN’s Alyssa Lile experienced firsthand the mission she joined PanCAN ...

PanCAN Chief Scientific & Medical Officer Dr. Anna Berkenblit talks about her experiences and highlights from the 2026 PanCAN ...

Imagine watching the sunrise from Uhuru Peak — 19,341 feet above sea level — knowing every step you took helped fuel progress for patients with pancreatic cancer and families. This is more than a trek ...

PanCAN PurpleStride, the ultimate walk to end pancreatic cancer, will take place the weekend of April 24, 2027. Find an event ...

Pittsburgh Event Day Volunteer Chair Kecia Scott spoke with PanCAN’s Paula Mukherjee about her journey as a caregiver and ...

The U.S. Food and Drug Administration has granted approval for a new drug targeting the mutations that drive more than 90% of pancreatic cancer cases — a sweeping advance for a disease that has few ...

For decades, pancreatic cancer research was defined by what seemed to be impossible. Researchers couldn’t target the mutations in the RAS family of proteins that drive more than 90% of cases. Often ...

The Pancreatic Cancer Action Network (PanCAN), the leading organization dedicated to advancing progress against pancreatic cancer, released a statement today following the full data from Revolution ...

I can’t think of a more exciting and hopeful time for pancreatic cancer than now. We are finally beginning to reap the benefits of decades of research into this challenging cancer. Because KRAS ...

The U.S. Food and Drug Administration (FDA) has approved a wearable medical device used in combination with a standard chemotherapy regimen for the treatment of adult patients with locally advanced ...

LOS ANGELES, Calif. – (January 13, 2026) – Pancreatic cancer remains the third-leading cause of cancer-related deaths in the United States, behind lung and colorectal cancers. According to the ...